Medicine 5th year, 11th lecture/part two (Dr. Sabir)
-
Upload
college-of-medicine-sulaymaniyah -
Category
Health & Medicine
-
view
1.771 -
download
1
description
Transcript of Medicine 5th year, 11th lecture/part two (Dr. Sabir)
Blood TransfusionBlood Transfusion
Dr. SabirDr. Sabir
30112549/ /30112549/ / MD-3 /49MD-3 /49 22
Blood TransfusionBlood Transfusion
. Types :. Types : 1- whole blood1- whole blood 2- packed RBCs2- packed RBCs 3- fresh frozen plasma3- fresh frozen plasma 4- platelets4- platelets 5- granulocyte transfusion5- granulocyte transfusion 6- cryopercipitate transfusion6- cryopercipitate transfusion
30112549/ /30112549/ / MD-3 /49MD-3 /49 33
Fresh Frozen PlasmaFresh Frozen Plasma
. Stored frozen, when thawed to 37. Stored frozen, when thawed to 37ooC should be C should be transfused within 24 hrstransfused within 24 hrs
. unit = 200ml increases the level of each clotting . unit = 200ml increases the level of each clotting factor 2-3%factor 2-3%
. Dose = 10-15 ml\Kg. Dose = 10-15 ml\Kg . Indications : - isolated factor deficiency. Indications : - isolated factor deficiency - warfarin reversal- warfarin reversal - liver disease- liver disease - massive blood transfusion- massive blood transfusion - antithrombin III deficiency when - antithrombin III deficiency when
heparin is needed heparin is needed
30112549/ /30112549/ / MD-3 /49MD-3 /49 44
Platelets Platelets . Stored at 20-24. Stored at 20-240 0 C for 5 days (shelf life) , C for 5 days (shelf life) , . Unit 50-70 ml, survival only for 1-7 days. Unit 50-70 ml, survival only for 1-7 days . Each unit increase platelet count by 5000-10,000. Each unit increase platelet count by 5000-10,000 . Side effects :. Side effects : - Rh sensitization- Rh sensitization - Anti A, anti B reaction- Anti A, anti B reaction - HLA typing - HLA typing - proliferating bacteria- proliferating bacteria . Indications :. Indications : a- thrombocytopenia (DIC, massive transfusion, a- thrombocytopenia (DIC, massive transfusion,
prophylactic preop, ITP) prophylactic preop, ITP) b- thrombasthenia (bleeding, prophylactic preop,)b- thrombasthenia (bleeding, prophylactic preop,)
30112549/ /30112549/ / MD-3 /49MD-3 /49 55
Transfusion ReactionsTransfusion Reactions
Acute Hemolytic TRAcute Hemolytic TR Non-immune-mediated hemolysisNon-immune-mediated hemolysis Delayed Hemolytic TRDelayed Hemolytic TR Febrile Non-hemolytic TRFebrile Non-hemolytic TR Allergic TRAllergic TR Anaphylactic & anaphylactoid RAnaphylactic & anaphylactoid R Transfusion-related acute lung injuryTransfusion-related acute lung injury Transfusion-associated circulatory overloadTransfusion-associated circulatory overload Metabolic reactionsMetabolic reactions Transfusion-associated GVHDTransfusion-associated GVHD Iron overloadIron overload Post-transfusion hemosiderosisPost-transfusion hemosiderosis AlloimmunizationAlloimmunization Post-transfusion purpuraPost-transfusion purpura Bacterial contamination reactionBacterial contamination reaction Transfusion-transmitted diseasesTransfusion-transmitted diseases
30112549/ /30112549/ / MD-3 /49MD-3 /49 66
Signs and Symptoms of AHTR
Chills , fever Facial flushing Hypotension Renal failure DIC Chest pain Dyspnea Generalized
bleeding
Hemoglobinemia Hemoglobinuria Shock Nausea & vomiting Back pain Pain along infusion
vein
30112549/ /30112549/ / MD-3 /49MD-3 /49 77
Acute Hemolytic Transfusion ReactionsAcute Hemolytic Transfusion Reactions
Acute onset within minutes or 1-2 hours
after transfuse incompatible blood
Most common cause is ABO-incompatible
transfusion
30112549/ /30112549/ / MD-3 /49MD-3 /49 88
Management of AHTRManagement of AHTR
Stop the transfusionStop the transfusion Keep IV fluidKeep IV fluid Notify patient’s physician and blood bankNotify patient’s physician and blood bank Take care of patient Take care of patient Perform bedside clerical checksPerform bedside clerical checks Return unit, set to blood bankReturn unit, set to blood bank Collect appropriate post transfusion bloodCollect appropriate post transfusion blood
sample for evaluationsample for evaluation
30112549/ /30112549/ / MD-3 /49MD-3 /49 99
Non-Immune-Mediated HemolysisNon-Immune-Mediated Hemolysis
CausesCauses Physical or chemical destruction ofPhysical or chemical destruction of bood: freezing, heating, drugs bood: freezing, heating, drugs solutions added to bloodsolutions added to blood Bacterial contaminationBacterial contamination
TreatmentTreatment
– depends on the causesdepends on the causesmild reaction mild reaction supportive treatment supportive treatmentsevere reaction severe reaction intensive treatment intensive treatment
30112549/ /30112549/ / MD-3 /49MD-3 /49 1010
Delayed Hemolytic Transfusion ReactionDelayed Hemolytic Transfusion Reaction
Signs & SymptomsSigns & Symptomsmild fever with chillmild fever with chillmild anemia mild anemia mild to moderate jaundicemild to moderate jaundiceUncommon Uncommon hemoglobinemia, hemoglobinemia,
Hemoglobinuria, shock, renal failureHemoglobinuria, shock, renal failure
30112549/ /30112549/ / MD-3 /49MD-3 /49 1111
Febrile Nonhemolytic Transfusion ReactionFebrile Nonhemolytic Transfusion Reaction
Signs & SymptomsSigns & Symptoms Fever with or without chillsFever with or without chills most symptoms are mildmost symptoms are mild severe reaction :- hypotension, severe reaction :- hypotension,
cyanosis, tachycardia, tachypnea, cyanosis, tachycardia, tachypnea, dyspnea, cough etc.dyspnea, cough etc.
30112549/ /30112549/ / MD-3 /49MD-3 /49 1212
Febrile Nonhemolytic ReactionFebrile Nonhemolytic Reaction
Treatment Treatment discontinue blood transfusion discontinue blood transfusion Antipyretic for feverAntipyretic for fever
PreventionPrevention using prestorage leukocyte –reduced red using prestorage leukocyte –reduced red
blood cell or plateletblood cell or platelet
30112549/ /30112549/ / MD-3 /49MD-3 /49 1313
Allergic Transfusion ReactionsAllergic Transfusion Reactions
Signs & SymptomsSigns & Symptoms
- Urticaria- Urticaria
- severe reactions are rare- severe reactions are rare
Therapy & PreventionTherapy & Prevention
- Antihistamine- Antihistamine
- Plasma – deficient blood - Plasma – deficient blood componentscomponents
30112549/ /30112549/ / MD-3 /49MD-3 /49 1414
Anaphylactic and Anaphylactoid Anaphylactic and Anaphylactoid reactionsreactions
Signs & SymptomsSigns & Symptoms
- - Anaphylactic Anaphylactic coughing, dyspnea, coughing, dyspnea, nausea, emesis, bronchospasm, flushing of nausea, emesis, bronchospasm, flushing of skin, chest pain, hypotension, abdominal skin, chest pain, hypotension, abdominal cramps, diarrhea, shock, and death.cramps, diarrhea, shock, and death.
- - AnaphylactoidAnaphylactoid (less severe) (less severe) urticaria, periorbital swelling, dyspnea, or urticaria, periorbital swelling, dyspnea, or perilaryngeal edemaperilaryngeal edema
30112549/ /30112549/ / MD-3 /49MD-3 /49 1515
Anaphylactic and Anaphylactoid Anaphylactic and Anaphylactoid reactionsreactions
Therapy and PreventionTherapy and Prevention Stop transfusionStop transfusion Keep IV line openKeep IV line open Medication :- epinephrine, Medication :- epinephrine,
corticosteroidcorticosteroid Wash RBCs and blood componentsWash RBCs and blood components Transfuse IgA deficiency bloodTransfuse IgA deficiency blood
30112549/ /30112549/ / MD-3 /49MD-3 /49 1616
Transfusion-related Acute Lung Injury Transfusion-related Acute Lung Injury (TRALI)(TRALI)
Acute and severe type of transfusion reactionAcute and severe type of transfusion reaction
Symptoms and signsSymptoms and signs FeverFever HypotensionHypotension TachypneaTachypnea DyspneaDyspnea Diffuse pulmonary infiltration on X-raysDiffuse pulmonary infiltration on X-rays Clinical of noncardiogenic pumonary Clinical of noncardiogenic pumonary
edemaedema
30112549/ /30112549/ / MD-3 /49MD-3 /49 1717
Transfusion-related Acute Lung InjuryTransfusion-related Acute Lung Injury (TRALI)(TRALI)
Therapy and PreventionTherapy and Prevention Adequate respiratory and hemodynamic Adequate respiratory and hemodynamic
supportive treatmentsupportive treatment If TRALI is caused by pt. Ab If TRALI is caused by pt. Ab use LPB use LPB If TRALI is caused by donor Ab If TRALI is caused by donor Ab no special no special
blood componentsblood components
30112549/ /30112549/ / MD-3 /49MD-3 /49 1818
Transfusion-associated Circulatory Transfusion-associated Circulatory Overload Overload (TACO)(TACO)
Patients at significant riskPatients at significant risk ChildrenChildren Elderly patientsElderly patients Chronic anemiaChronic anemia Cardiac diseaseCardiac disease Thalassemia major or Sickle cell Thalassemia major or Sickle cell
diseasedisease
30112549/ /30112549/ / MD-3 /49MD-3 /49 1919
Symptoms and SignsSymptoms and Signs
DyspneaDyspnea CoughingCoughing CyanosisCyanosis OrthopneaOrthopnea Chest discomfortChest discomfort
HeadacheHeadache RestlessnessRestlessness TachycardiaTachycardia Systolic Systolic
hypertension hypertension increase > 50 increase > 50 mm.Hgmm.Hg
30112549/ /30112549/ / MD-3 /49MD-3 /49 2020
TherapyTherapy
Rapid reduction of hypervolemiaRapid reduction of hypervolemia Respiratory and cardiac supportRespiratory and cardiac support Oxygen therapyOxygen therapy DiureticDiuretic Therapeutic phlebotomyTherapeutic phlebotomy
30112549/ /30112549/ / MD-3 /49MD-3 /49 2121
Metabolic ReactionMetabolic Reaction
Citrate toxicityCitrate toxicity HyperkalemiaHyperkalemia HypothermiaHypothermia Coagulopathy in massive transfusionCoagulopathy in massive transfusion Air embolismAir embolism
30112549/ /30112549/ / MD-3 /49MD-3 /49 2222
Transfusion-associated Graft-versus-HostTransfusion-associated Graft-versus-Host Disease Disease ( TA-GVHD)( TA-GVHD)
Patient at riskPatient at risk
Bone marrow transplantation
Chemotherapy
Radiation treatment
Newborn
30112549/ /30112549/ / MD-3 /49MD-3 /49 2323
Graft-versus-Host ReactionGraft-versus-Host Reaction
Signs & SymptomsSigns & Symptoms
Onset ~ 3 to 30 days after transfusion Clinical significant – pancytopenia Other effects include fever, liver enzyme,
copious watery diarrhea,
erythematous skin erythroderma
and desquamation
30112549/ /30112549/ / MD-3 /49MD-3 /49 2424
Graft-versus-Host ReactionGraft-versus-Host Reaction
TherapyTherapy
Drugs :- corticosteroids, methotrexate, azathioprine,Drugs :- corticosteroids, methotrexate, azathioprine,
antithymocyte globulinantithymocyte globulin
But no adequate therapyBut no adequate therapy
PreventionPrevention
Irradiation of Blood Components Irradiation of Blood Components
avoid potential fatalitiesavoid potential fatalities
30112549/ /30112549/ / MD-3 /49MD-3 /49 2525
Iron overloadIron overload
1 unit of PRCs has ~ 250 mg of Iron
Removed by body 1 mg / day
accumulate iron Hemosiderosis
30112549/ /30112549/ / MD-3 /49MD-3 /49 2626
Posttransfusion HemosiderosisPosttransfusion Hemosiderosis
Affected organ :- Affected organ :- heart, liver, endocrine glandsheart, liver, endocrine glands
Signs & SymptomsSigns & Symptoms - - muscle weakness, fatigue, weight loss, mild muscle weakness, fatigue, weight loss, mild
jaundice, anemia, mild diabetes, and cardiac jaundice, anemia, mild diabetes, and cardiac arrhythmiaarrhythmia
Therapy Therapy Iron – chelating agent Iron – chelating agent Prevention Prevention transfuse with young RBCs transfuse with young RBCs
30112549/ /30112549/ / MD-3 /49MD-3 /49 2727
AlloimmunizationAlloimmunization
Signs & SymptomsSigns & Symptomsmild mild slight fever and Hb slight fever and Hbsevere severe platelet refractoriness platelet refractoriness with bleedingwith bleeding
Therapy & PreventionTherapy & Preventiondepends on type and severitydepends on type and severity
30112549/ /30112549/ / MD-3 /49MD-3 /49 2828
Posttransfusion PurpuraPosttransfusion Purpura
Rare complicationRare complication Rapid onset of thrombocytopenia as Rapid onset of thrombocytopenia as
a result of anamnestic production of a result of anamnestic production of platelet alloantibodyplatelet alloantibody
Usually occurs in multiparous womanUsually occurs in multiparous womanPurpura and thrombocytopenia Purpura and thrombocytopenia occuroccur ~ 1-2 wk after transfusion~ 1-2 wk after transfusion
30112549/ /30112549/ / MD-3 /49MD-3 /49 2929
Posttransfusion PurpuraPosttransfusion Purpura
Therapy and PreventionTherapy and PreventionCorticosteroidsCorticosteroidsExchange transfusionExchange transfusionPlasmapheresisPlasmapheresis
30112549/ /30112549/ / MD-3 /49MD-3 /49 3030
Bacterial contamination reactionBacterial contamination reaction
Cause Cause gram –ve, gram +ve bacteriagram –ve, gram +ve bacteria
most frequentmost frequent – – Yersinia enterocoliticaYersinia enterocolitica
PathophysiologyPathophysiology Bacteria growing in cold temperatureBacteria growing in cold temperature
Produced Produced endotoxinendotoxin
30112549/ /30112549/ / MD-3 /49MD-3 /49 3131
Symptoms & SignsSymptoms & Signs
Acute onset within ~ 30 minAcute onset within ~ 30 min after transfusionafter transfusion
Dryness and flushing skinDryness and flushing skin
Fever, hypotension, shaking chills, muscle pain, Fever, hypotension, shaking chills, muscle pain,
vomitting, abdominal cramps, bloody diarrhea, vomitting, abdominal cramps, bloody diarrhea,
hemoglobinuria, shock, renal failure, and DIC.hemoglobinuria, shock, renal failure, and DIC.
Treatment: broad-spectrum antibioticsTreatment: broad-spectrum antibiotics
30112549/ /30112549/ / MD-3 /49MD-3 /49 3232
Transfusion – Transmitted DiseasesTransfusion – Transmitted Diseases
Viral InfectionsViral InfectionsHepatitis Viruses :- HBV, HCVHepatitis Viruses :- HBV, HCVRetroviruses :- HIVRetroviruses :- HIVHerpesviruses :- CMV, EBVHerpesviruses :- CMV, EBVParvovirus :- Parvovirus :- Human B19 parvovirusHuman B19 parvovirus
Prion :- infectious particle of CJD Prion :- infectious particle of CJD
30112549/ /30112549/ / MD-3 /49MD-3 /49 3333
Transfusion – Transmitted DiseasesTransfusion – Transmitted Diseases
Bacterial InfectionBacterial InfectionGram -ve and +veGram -ve and +veSyphilisSyphilisLyme disease Lyme disease
30112549/ /30112549/ / MD-3 /49MD-3 /49 3434
Transfusion – Transmitted DiseasesTransfusion – Transmitted Diseases
Parasitic InfectionsParasitic Infections– MalariaMalaria– Chagas diseaseChagas disease– ToxoplasmosisToxoplasmosis– LeishmaniasisLeishmaniasis
30112549/ /30112549/ / MD-3 /49MD-3 /49 3535
Steps to take when a transfusion Steps to take when a transfusion reaction occursreaction occurs
Stop the transfusion immediatelyStop the transfusion immediately Leave the needle in the vein and Leave the needle in the vein and
begin infusing normal salinebegin infusing normal saline Obtain vital signsObtain vital signs Begin OBegin O
22 if pulmonary symptoms are if pulmonary symptoms are
prominentprominent Carry out PE : lung, heart, skin, signs Carry out PE : lung, heart, skin, signs
of abnormal bleedingof abnormal bleeding
30112549/ /30112549/ / MD-3 /49MD-3 /49 3636
Steps to take when a transfusion Steps to take when a transfusion reaction occursreaction occurs
Obtain a new blood sample for Obtain a new blood sample for repeat RBC compatibility test and repeat RBC compatibility test and inspection for hemolysisinspection for hemolysis
Obtain a urine sample if the patient Obtain a urine sample if the patient can voidcan void
Obtain a chest x-ray if pulmonary Obtain a chest x-ray if pulmonary symptoms are prominentsymptoms are prominent
Begin definitive treatmentBegin definitive treatment